Can Wegovy Cause Erectile Dysfunction?

You've just started Wegovy and something has changed below the belt

This is the situation a surprising number of men find themselves in. The first few weeks on semaglutide, the active ingredient in Wegovy, can bring nausea, fatigue, disrupted appetite and a general sense of your body adjusting to something new. None of that is conducive to feeling like yourself, let alone to sexual performance. It's worth separating that short-term disruption from a genuine, persisting change in erectile function.

Wegovy's UK Patient Information Leaflet and its Summary of Product Characteristics, published on the electronic Medicines Compendium, list recognised side effects in detail. ED does not appear among them. The large STEP 1 trial (1,961 adults, 68 weeks of treatment) reported an extensive safety profile; erectile dysfunction was not identified as a treatment-related event. If you're experiencing something new, it's real and it deserves attention, but the medicine itself is an unlikely direct cause.

What matters more, in most cases, is what was already going on before the first injection. Obesity, high blood pressure, raised blood glucose and chronically low testosterone are among the most common drivers of ED in adult men, and many people starting Wegovy have one or more of those conditions. Those background factors don't disappear on week one. They take time to shift.

How obesity-related conditions connect to erectile dysfunction

The NHS guidance on semaglutide explains that the medicine works by mimicking a gut hormone called GLP-1, which regulates appetite and blood sugar. Weight reduction follows from reduced food intake and improved metabolic signalling. What the NHS page also makes clear is that the medicine is a treatment for a health condition, not a cosmetic tool — and that condition, obesity, has well-documented effects on vascular and hormonal health.

Chronic obesity raises cardiovascular risk, promotes insulin resistance and suppresses testosterone production through a process involving the aromatisation of androgens in fat tissue. All three of those pathways independently worsen erectile function. So a man who has carried significant excess weight for years may already have some degree of vascular ED before he opens his first Wegovy pen. It isn't caused by the injection; it was already there.

The practical implication is this: if you're in the early weeks of treatment and noticing changes in libido or performance, it is more likely connected to nausea, poor sleep, reduced caloric intake or pre-existing vascular factors than to a pharmacological effect of semaglutide. Understanding the broader semaglutide and ED question in full can help put that into context.

Does weight loss on semaglutide actually help with ED?

There is a reasonable body of observational and mechanistic evidence suggesting it can, in men whose ED is linked to obesity-related causes. As blood pressure falls, insulin sensitivity improves and testosterone levels begin to recover with sustained weight loss, the vascular and hormonal conditions that support healthy erectile function tend to improve. A number of researchers have flagged this as a plausible benefit of GLP-1 treatment, though large randomised trials specifically examining erectile function as a primary outcome are still limited.

One realistic note: weight loss takes months to produce meaningful metabolic change. You won't see the full picture at week four or even week twelve. Men who give treatment a proper run and focus on the lifestyle components alongside it (adequate protein, consistent movement, sleep quality) report the best outcomes overall. Pairing a clear understanding of how Wegovy supports weight loss with realistic timelines helps manage expectations. And if libido concerns persist well beyond the initial adjustment period, that is a conversation for your prescriber, not something to ignore.

It's also worth keeping in mind that other early-treatment effects (gas, digestive discomfort and changes in appetite) are common companions in those first weeks, and some patients also wonder whether Wegovy can trigger gout as another aspect of how the body responds to rapid metabolic change. If you're curious how GI effects tend to play out, reading about the GI side-effect pattern may reassure you that many resolve as the body settles.

When to raise this with a clinician, and how

If erectile difficulties are persisting, worsening, or clearly began after starting Wegovy rather than preceding it, raise it. Not with a forum. Not with a search engine. With a prescriber who has access to your medical history. There are a few reasons this matters practically. First, some medicines prescribed alongside Wegovy (for blood pressure or depression, for instance) are well-established contributors to ED, and a prescriber can review the whole picture. Second, persistent ED in any context is a recognised early marker of cardiovascular risk, and it warrants proper assessment regardless of what treatment you're on.

The side-effect picture for Wegovy more broadly is something our clinical team reviews with every patient. If you have questions before starting, or mid-treatment concerns you want a professional eye on, speaking to our prescribers is a straightforward next step. For anything that feels urgent or you're unsure whether to act on, the MHRA Yellow Card scheme lets you report unexpected effects directly to the regulator, and your GP is always the right first call for anything that needs a face-to-face review.